These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes? Byrne R; Yost SE; Kaplan B Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295 [No Abstract] [Full Text] [Related]
28. Controlled trial of RS-61443 in renal transplant patients receiving cyclosporine monotherapy. Salaman JR; Griffin PJ; Johnson RW; Kohlhaw K; Land W; Moore R; Pichlmayr R; Sells R Transplant Proc; 1993 Feb; 25(1 Pt 1):695-6. PubMed ID: 8438441 [No Abstract] [Full Text] [Related]
29. Therapeutic monitoring of mycophenolate mofetil. Jeong H; Kaplan B Clin J Am Soc Nephrol; 2007 Jan; 2(1):184-91. PubMed ID: 17699403 [No Abstract] [Full Text] [Related]
30. Role of cyclosporine A in the treatment of acute renal allograft rejection. Gascon M; Donnelly S; Lowry RP Transplant Proc; 1987 Aug; 19(4):3481-5. PubMed ID: 3303519 [No Abstract] [Full Text] [Related]
31. Mycophenolate-update after it has come of age. GrinyĆ³ JM Nephrol Dial Transplant; 1999 Jan; 14(1):31-4. PubMed ID: 10052471 [No Abstract] [Full Text] [Related]
32. The role of immunosuppression in recurrence of hepatitis C. Lake JR Liver Transpl; 2003 Nov; 9(11):S63-6. PubMed ID: 14586898 [TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil for prevention of acute rejection. Moore R; Griffin P; Darby C; Jurewicz A; Lord R Lancet; 1995 Jul; 346(8969):253. PubMed ID: 7616827 [No Abstract] [Full Text] [Related]
34. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467 [No Abstract] [Full Text] [Related]
36. Current status of immunosuppressive agents for solid organ transplantation in children. Coelho T; Tredger M; Dhawan A Pediatr Transplant; 2012 Mar; 16(2):106-22. PubMed ID: 22360399 [TBL] [Abstract][Full Text] [Related]
37. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102 [TBL] [Abstract][Full Text] [Related]
38. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation. Allison AC; Eugui EM Transplant Proc; 1994 Dec; 26(6):3205-10. PubMed ID: 7998117 [No Abstract] [Full Text] [Related]
39. [A new immunosuppressor: CellCept]. Mouly-Bandini A Presse Med; 2001 Jan; 30(2):66-7. PubMed ID: 11244816 [No Abstract] [Full Text] [Related]
40. Mycophenolate mofetil--a new immunosuppressant for organ transplantation. Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]